top of page
About Us
Since forming DeepLook in 2019, the company secured broad software patent protection and FDA clearance of its first product, DL Precise™.
​
Now poised for rapid commercialization across the healthcare industry, the founders have recruited a veteran senior management team, each with decades of medtech and imaging experience. This team will fuel rapid adoption through strategic partnerships with their long-standing relationships and industry gravitas.
Executive Leadership
Board of Directors
Soledad Delgadillo
Board Observer,
OKG Capital
Karim Galzahr
Board Director,
OKG Capital
Board of Advisors
Our Partners
bottom of page